Ethyl-EPA Treatment of Prodromal Patients
NCT00634361
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
7
Enrollment
OTHER
Sponsor class
Conditions
Schizophrenia Prodrome
Interventions
DRUG:
ethyl-eicosapentaenoic acid
Sponsor
Yale University